Imperial College of Science, Technology and Medicine
ICL is a science-based institution with a reputation for excellence in teaching and research, consistently rated amongst the world's best universities. Our primary tasks as a project partner are the provision expertise and capacity in:
- metabolomics and fluxomics in toxicological models and human samples;
- omics integration;
- computational chemistry with specific reference to advanced moleculardynamics.
ICL will contribute to the HeCaToS project through two research departments.
The Biomolecular Medicine (BMM) section, established by Prof. Jeremy Nicholson within ICL is a world-leading group in metabolomics. Together with over 50 researchers, BMM possesses substantial analytical facilities (CE-MS, LC-QTOF-MS, LC-TQ-MS,LC-Orbitrap-MS, GC-MS, NMR) with the capacity to conduct large (n>10,000) molecular profiling studies. BMM’s work in toxicological applications of metabolomics extends to several hundred manuscripts.
The Institute for Chemical Biology (ICB) within ICL is a world-leading centre forchemical biology with strong links with pharmaceutical and chemical industries thatspecialises in modelling, measurement and manipulation of protein-protein and proteinlipidinteractions.